Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease

被引:104
作者
Shaw, MJ
Talley, NJ
Beebe, TJ
Rockwood, T
Carlsson, R
Adlis, S
Fendrick, AM
Jones, R
Dent, J
Bytzer, P
机构
[1] Park Nicollet Med Ctr, Hlth Res Ctr, Minneapolis, MN 55416 USA
[2] Univ Sydney, Nepean Hosp, Dept Med, Penrith, Australia
[3] Univ Minnesota, Clin Outcomes Res Ctr, Minneapolis, MN USA
[4] AstraZeneca, Molndal, Sweden
[5] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA
[6] Guys Kings & St Thomas Sch Med, Div Primary Care & Publ Hlth Serv, London, England
[7] Royal Adelaide Hosp, Dept Gastrointestinal Med, N Terrace Adelaide, SA, Australia
[8] Glostrup Univ Hosp, Dept Med Gastroenterol, Glostrup, Denmark
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Brief, reliable, and valid self-administered questionnaires could facilitate the diagnosis of gastroesophageal reflux disease in primary care. We report the development and validation of such an instrument. METHODS: Content validity was informed by literature review, expert opinion, and cognitive interviewing of 50 patients resulting in a 22-item survey. For psychometric analyses, primary care patients completed the new questionnaire at enrollment and at intervals ranging from 3 days to 3 wk. Multitrait scaling, test-retest reliability, and responsiveness were assessed. Predictive validity analyses of all scales and items used specialty physician diagnosis as the "gold standard." RESULTS: Iterative factor analyses yielded three scales of four items each including heartburn, acid regurgitation, and dyspepsia. Multitrait scaling criteria including internal consistency, item interval consistency, and item discrimination were 100% satisfied. Test-retest reliability was high in those reporting stable symptoms. Scale scores significantly changed in those reporting a global change. Regressing specialty physician diagnosis on the three scales revealed significant effects for two scales (heartburn and regurgitation). Combining the two significant scales enhanced the strength of the model. Symptom response to self-directed treatment with nonprescription antisecretory medications was highly predictive of the diagnosis also, although the item demonstrated poor validity and reliability. CONCLUSIONS: A brief, simple 12-item questionnaire demonstrated validity and reliability and seemed to be responsive to change for reflux and dyspeptic symptoms. (Am J Gastroenterol 2001;96.52-57. (C) 2001 by Am. Coll. of Gastroenterology).
引用
收藏
页码:52 / 57
页数:6
相关论文
共 21 条
[1]  
[Anonymous], MEASURING FUNCTIONIN
[2]  
Carlsson R, 1998, SCAND J GASTROENTERO, V33, P1023
[3]  
Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297
[4]   An evidence-based appraisal of reflux disease management - the Genval workshop report [J].
Dent, J ;
Brun, J ;
Fendrick, AM ;
Fennerty, MB ;
Janssens, J ;
Kahrilas, PJ ;
Lauritsen, K ;
Reynolds, JC ;
Shaw, M ;
Talley, NJ .
GUT, 1999, 44 :S1-S16
[5]  
Dillman D.A., 1978, MAIL TELEPHONE SURVE
[6]   QUALITY-OF-LIFE IN PATIENTS WITH UPPER GASTROINTESTINAL SYMPTOMS - AN IMPROVED EVALUATION OF TREATMENT REGIMENS [J].
DIMENAS, E ;
GLISE, H ;
HALLERBACK, B ;
HERNQVIST, H ;
SVEDLUND, J ;
WIKLUND, I .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 (08) :681-687
[7]   The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain [J].
Fass, R ;
Fennerty, MB ;
Ofman, JJ ;
Gralnek, IM ;
Johnson, C ;
Camargo, E ;
Sampliner, RE .
GASTROENTEROLOGY, 1998, 115 (01) :42-49
[8]   Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease [J].
Fass, R ;
Ofman, JJ ;
Gralnek, IM ;
Johnson, C ;
Camargo, E ;
Sampliner, RE ;
Fennerty, MB .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (18) :2161-2168
[9]   MEASUREMENT OF HEALTH-STATUS - ASCERTAINING THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE [J].
JAESCHKE, R ;
SINGER, J ;
GUYATT, GH .
CONTROLLED CLINICAL TRIALS, 1989, 10 (04) :407-415
[10]  
JONES RH, 1995, EUR J GEN PRACT, V1, P149